Biomarker exploration in patients undergoing boron neutron capture therapy (BNCT) for malignant melanoma and angiosarcoma.
Not Applicable
- Conditions
- Malignant melanoma of skin and angiosarcoma of skin
- Registration Number
- JPRN-UMIN000043564
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
Obvious disseminated lesions The lesion has received radiotherapy in excess of 75 Gy. Active lesions/active multiple cancers other than the target lesion Active implantable medical devices such as implantable cardiac pacemakers are implanted History of BNCT treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis of metabolites (including proteins) and genes in peripheral blood and urine to establish a measurement system for biomarkers of BNCT efficacy
- Secondary Outcome Measures
Name Time Method